|Articles|November 27, 2006
Review of Alpha-Agonist Formulations and Neuroprotection
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
ONL Therapeutics reports positive phase 1b data for xelafaslatide in geographic atrophy
2
Alcon raises offer in amended deal to acquire STAAR Surgical
3
Neurotrophic keratitis outcomes improve with early, stage-based care
4
Ocular Therapeutix accelerates NDA submission plans for AXPAXLI for wet AMD
5










































.png)


